| Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors S Konermann, P Lotfy, NJ Brideau, J Oki, MN Shokhirev, PD Hsu Cell 173 (3), 665-676. e14, 2018 | 1123 | 2018 |
| Inference of CRISPR edits from Sanger trace data D Conant, T Hsiau, N Rossi, J Oki, T Maures, K Waite, J Yang, S Joshi, ... The CRISPR journal 5 (1), 123-130, 2022 | 737 | 2022 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 694 | 2020 |
| Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses R Wang, CR Simoneau, J Kulsuptrakul, M Bouhaddou, KA Travisano, ... Cell 184 (1), 106-119. e14, 2021 | 378 | 2021 |
| BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 AJ Samelson, QD Tran, R Robinot, L Carrau, VV Rezelj, AM Kain, M Chen, ... Nature cell biology 24 (1), 24-34, 2022 | 77* | 2022 |
| Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication CG Williams, AS Jureka, JA Silvas, AM Nicolini, SA Chvatal, ... Cell Reports 36 (5), 2021 | 74 | 2021 |
| Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen A Mac Kain, G Maarifi, SM Aicher, N Arhel, A Baidaliuk, S Munier, ... Nature Communications 13 (1), 2442, 2022 | 42 | 2022 |
| Inference of CRISPR edits from sanger trace data. CRISPR J. 5, 123–130 D Conant, T Hsiau, N Rossi, J Oki, T Maures, K Waite, J Yang, S Joshi, ... | 41 | 2021 |
| Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses R Wang, CR Simoneau, J Kulsuptrakul, M Bouhaddou, K Travisano, ... BioRxiv, 2020 | 26 | 2020 |
| Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2 IP Chen, JE Longbotham, S McMahon, RK Suryawanshi, MM Khalid, ... Cell Reports 40 (3), 2022 | 24 | 2022 |
| Novel CRISPR-associated gene-editing systems discovered in metagenomic samples enable efficient and specific genome engineering RC Lamothe, MD Storlie, DA Espinosa, R Rudlaff, P Browne, J Liu, ... The CRISPR Journal 6 (3), 243-260, 2023 | 4 | 2023 |
| Novel and engineered type II CRISPR systems from uncultivated microbes with broad genome editing capability LM Alexander, DS Aliaga Goltsman, J Liu, JL Lin, MM Temoche-Diaz, ... The CRISPR Journal 6 (3), 261-277, 2023 | 2 | 2023 |
| BRD2 inhibition blocks SARS-CoV-2 infection in vitro by reducing transcription of the host cell receptor ACE2 AJ Samelson, QD Tran, R Robinot, L Carrau, VV Rezelj, A Mac Kain, ... | | 2021 |
| Validation of CRISPR Gene Knockouts in U2OS Cell Lines with Global Proteomic Analysis Using Data-Independent Acquisition Mass Spectrometry J Oki, V Dozio, D Conant, T Maures, M Gut, Y Feng, K Beeler, S Pattison, ... MOLECULAR THERAPY 28 (4), 452-452, 2020 | | 2020 |
| .(2021) Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses R Wang, CR Simoneau, J Kulsuptrakul, M Bouhaddou, KA Travisano, ... Cell 184, 106-119, 0 | | |
